Yale University

HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

TitleHIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
Publication TypeJournal Article
Year of Publication2011
AuthorsAltice, Frederick L., Douglas R. Bruce, Gregory M. Lucas, Paula J. Lum, Todd P. Korthuis, Timothy P. Flanigan, Chinazo O. Cunningham, Lynn E. Sullivan, Pamela Vergara-Rodriguez, David A. Fiellin, Adan Cajina, Michael Botsko, Vijay Nandi, Marc N. Gourevitch, and Ruth Finkelstein
Corporate AuthorsBHIVES Collaborative
JournalJournal of acquired immune deficiency syndromes (1999)
Volume56 Suppl 1
PaginationS22-32
Date Published2011 Mar 1
ISSN1944-7884
KeywordsAlcoholism, Anti-HIV Agents, Buprenorphine, CD4 Lymphocyte Count, Female, HIV Infections, HIV-1, Humans, Male, Middle Aged, Naloxone, Narcotic Antagonists, Opiate Substitution Treatment, Opioid-Related Disorders, Risk Factors, RNA, Viral, Treatment Outcome
AbstractHaving opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes.
DOI10.1007/s11606-010-1323-z
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links